The business of anti-aging has been the focus for scientists and anyone with a gray hair, for as long as we all can remember. Daily in magazines and on television, we are bombarded with buzzwords like free radicals, anti-aging, inflammation, preserving, skin-repair and so on. There are numerous companies all over the world dedicated to curing everything from cancer to wrinkles. Rather than focus on a specific ailment, AgeX Therapeutics, a biotechnology company formed in 2017, puts the spotlight on aging itself as the “disease”. CEO Michael West, sits down to share his vision for AgeX, as they work on developing solutions, using powerful regenerative treatments to combat aging and its effects on the human body. He also weighs in on the compelling scientific advancements that have come along in the past 10-15 years in this field. Researchers are now starting to unify on what aging is and are forming a biology, so to speak. This allows like-minded folks to pool resources, ideas, energy and their scientific minds to solve the significant unmet needs in the age-related disease market.